(Q34996110)

5 August 2017

1 reference

title

Progress in the treatment of acute myeloid leukaemia in adults (English)

1 reference

5 August 2017

1 reference

1

Adrian Newland

1 reference

5 August 2017

1 August 2002

1 reference

International Journal of Hematology

5 August 2017

1 reference

5 August 2017

76 Suppl 1

1 reference

5 August 2017

253-258

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03165254

5 August 2017

0 references

cites work

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen

1 reference

12 December 2020

Characterization and modulation of drug transport kinetics in K562 c1.6 daunorubicin-resistant cell line

1 reference

12 December 2020

Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Ad

1 reference

12 December 2020

Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group

1 reference

12 December 2020

United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia

1 reference

12 December 2020

Acute promyelocytic leukemia: from genetics to treatment

1 reference

12 December 2020

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

1 reference

12 December 2020

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

1 reference

12 December 2020

FLAG (fludarabine + high-dose cytarabine + G-CSF): an effective and tolerable protocol for the treatment of 'poor risk' acute myeloid leukemias.

1 reference

12 December 2020

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

1 reference

12 December 2020

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

12 December 2020

Graft-versus-leukemia reactions after bone marrow transplantation

1 reference

12 December 2020

P-glycoprotein expression on acute myeloid leukaemia blast cells at diagnosis predicts response to chemotherapy and survival

1 reference

12 December 2020

A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group

1 reference

12 December 2020

The frequency of long-term remission in patients with acute myelogenous leukaemia treated with conventional maintenance chemotherapy: a study of 760 patients with a minimal follow-up time of 6 years

1 reference

12 December 2020

High-dose chemotherapy and autologous bone marrow transplantation in acute myeloid leukemia

1 reference

12 December 2020

Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Par

1 reference

12 December 2020

A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study

1 reference

12 December 2020

Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients

1 reference

12 December 2020

Prognostic factors in adult de novo myelodysplastic syndromes treated by intensive chemotherapy.

1 reference

12 December 2020

Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia

1 reference

12 December 2020

Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.

1 reference

12 December 2020

Continuous intravenous infusion of high-dose recombinant interleukin-2 for acute myeloid leukaemia--a phase II study

1 reference

12 December 2020

1 reference

12 December 2020

P-glycoprotein expression as unfavorable prognostic factor in acute myeloid leukemia.

1 reference

12 December 2020

Morphological classification, response to therapy, and survival in 263 adult patients with acute nonlymphoblastic leukemia

1 reference

12 December 2020

Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation

1 reference

12 December 2020

Treatment of newly diagnosed acute myelogenous leukemia with granulocyte-macrophage colony-stimulating factor (GM-CSF) before and during continuous-infusion high-dose ara-C + daunorubicin: comparison to patients treated without GM-CSF.

1 reference

12 December 2020

Administration of rHuGM-CSF activates monocyte reactive oxygen species secretion and adhesion molecule expression in vivo in patients following high-dose chemotherapy

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03165254

1 reference

PubMed ID

12430860

Dimensions Publication ID

5 August 2017

0 references

1 reference

PubMed ID

12430860